RTOG -1012


Clinical Trial Title

RTOG -1012

Trial Status

Open to Enrollment

Start Date

September 6, 2013


Trial Type

Cancer (Oncology)

Specific Condition

Lung Cancer


Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer

Eligibility Criteria

Patients being treated with combination chemotherapy (definitive or adjuvant) and radiation therapy once daily for small cell or non-small cell lung cancer; at least 5 cm of the esophagus must be in the 60 Gy isodose volume.

Patients must be ≥ 18 years of age

Patients must be able to swallow thick liquids during treatment

Patients must not have a known hypersensitivity to honey

Patients must not have metastatic disease?



IRB Number

Legacy IRB


Sponsored by: RTOG Radiation Therapy Oncology Group

Principal Investigator Name

Andrew Kee, MD

Contact Name

Legacy Oncology Clinical Research



Contact Fax


Last Updated: Wednesday, September 18, 2013 01:40:18 PM